Elephas is collaborating with Mithrl, an AI company focused on accelerating research through its Scientific Decision Engine (SDE), the company announced recently.

“Partnering with Mithrl enables us to more fully leverage the richness of our functional profiling data and showcase the power of Agentic AI,” Elephas CEO Hinco Gierman said in a statement. “By integrating these data with external datasets, we’re incredibly impressed with the speed at which Mithrl is able to generate novel insights that can better understand the biology of response and generate insights that may help guide translational research and therapeutic development.”

According to a release, combining the two approaches establishes a foundation for integrating functional tumor profiling with AI-driven analysis to support more scalable and systematic discovery of novel immunotherapy response signals.

The biotech company will be co-presenting new data from this collaboration next week at the 2026 American Association for Cancer Research (AACR) Annual Meeting.